vcfirmsdirectory.com

Venture capital · Growth stage · Est. 2006

Longitude Capital

Longitude Capital is a healthcare-focused venture growth investor backing biotechnology, medical technology and health solutions companies, in both private and public markets, with offices in Menlo Park and Boston.

Menlo Park · BostonRegistered · Menlo Park
New investments · 12 months
Fund vehiclesPublic
6
6 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 26 Oct 2026, 16:50 CETSources: longitudecapital.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Longitude Capital joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Longitude Capital right for your round?

Is Longitude Capital a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
6
6 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

LONGITUDE VENTURE PARTNERS IV, L.P.US private fund · Active · United States · $1.1B gross assets · filed 21 Aug 2026
LONGITUDE VENTURE PARTNERS III, L.P.US private fund · Active · United States · $513.6M gross assets · filed 21 Aug 2026
LONGITUDE VENTURE PARTNERS V, L.P.US private fund · Active · United States · $402.8M gross assets · filed 21 Aug 2026
LONGITUDE PRIME FUND, L.P.US private fund · Active · United States · $290.7M gross assets · filed 21 Aug 2026
LONGITUDE 103.8 EAST, L.P.US private fund · Active · United States · $105.2M gross assets · filed 21 Aug 2026
LONGITUDE VENTURE PARTNERS II, L.P.US private fund · Active · United States · $75.4M gross assets · filed 21 Aug 2026
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds Longitude Capital joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

1 round in the last 12 months

Round sizes, Longitude Capital’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

89bioAEON BiopharmaAimmune TherapeuticsAirNexis TherapeuticsAkebia TherapeuticsAlentis TherapeuticsAlpha-9Amarin CorporationAmphora MedicalAmunix Pharmaceuticalsand 60 more

Portfolio and exits

Every company Longitude Capital backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Longitude Capital puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Longitude Capital

Events where Longitude Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Longitude Capital’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

21 Aug 2026Fund filingForm ADV filed by LONGITUDE CAPITAL MANAGEMENT CO., LLC: 6 private funds, $2.4B in gross assets.SEC Form ADV · public record
18 Jun 2026New deal
12 Nov 2024New deal
24 Apr 2024New deal
19 Dec 2023New deal

Founders also look at

Frequently asked questions

Longitude Capital is based in Menlo Park, United States. It also has an office in Boston.

In 2006.

6 fund vehicles are on public registers (SEC adviser filings), including LONGITUDE VENTURE PARTNERS IV, L.P., LONGITUDE VENTURE PARTNERS III, L.P. and LONGITUDE VENTURE PARTNERS V, L.P.

Stages: Growth. Sectors: Biotech, Medtech. From the firm’s own website.

Builds a balanced portfolio of clinical- and commercial-stage healthcare companies with clinically de-risked assets and reasonable valuations, targeting returns within three to five years. Sources deals through industry networks and thematic research, uses flexible structures, and works with management and syndicate partners on strategy, hiring and capital raising. From the firm’s own website.

Longitude Capital lists 70 portfolio companies on its website, including 89bio, AEON Biopharma, Aimmune Therapeutics, AirNexis Therapeutics and Akebia Therapeutics.

Firms whose websites list some of the same companies include Frazier Life Sciences, RA Capital and Alta Partners.

Know before Longitude Capital’s next round is announced.

PRO tracks Longitude Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Longitude CapitalGet Longitude Capital’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.